MFS
ESPR

Mirabella Financial Services’s Esperion Therapeutics ESPR Stock Holding History

Mirabella Financial Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
37,481
+18,623
+99% +$52.1K 0.01% 643
2026
Q1 		$51.7K Buy
+18,858
New +$59.7K ﹤0.01% 882
2024
Q1 		– Sell
-42,200
Closed -$126K – 573
2023
Q4 		$126K Buy
+42,200
New +$54.7K 0.02% 391

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Mirabella Financial Services's ESPR Position: Q2 2026 in Review

Mirabella Financial Services increased its Esperion Therapeutics (ESPR) stake by 99% in Q2 2026, buying an estimated $52.1K and bringing the position to 37,481 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #643.

Mirabella Financial Services first reported a position in ESPR in Q4 2023 and has held it in 3 quarters since. The position peaked at $126K in Q4 2023. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Mirabella Financial Services held 37,481 shares of Esperion Therapeutics worth $118K as of Q2 2026.
  • Mirabella Financial Services bought 18,623 Esperion Therapeutics shares in Q2 2026, an estimated $52.1K.
  • Esperion Therapeutics made up 0.01% of Mirabella Financial Services's portfolio in Q2 2026, its #643 holding.
  • Mirabella Financial Services first reported a position in Esperion Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Mirabella Financial Services's Esperion Therapeutics position peaked at $126K in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.